Arkolith/Insider Trading/SER/Form 4

Moreadith Randall

Chief Scientific OfficerSerina Therapeutics, Inc. (SER) · full profile →Form 4 · filed Aug 27, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$331K
Net Open-Market Flow
-$331K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 26, 2025Option exercise(M)46K$0.06$3K46K
Aug 26, 2025Sell(S)46K$7.01$320K0
Aug 25, 2025Option exercise(M)2K$0.06$1232K
Aug 25, 2025Sell(S)2K$5.65$12K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 26, 2025Option exercise(M)46K—$0422K
Aug 25, 2025Option exercise(M)2K—$0467K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001301120-25-000005) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML